Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry

PURPOSE: Patients with uncontrolled asthma despite high doses of inhaled corticosteroid therapy plus another controller are defined as severe asthmatics. Tiotropium bromide respimat (TBR) is the only long-acting muscarinic antagonists (LAMA) approved for severe asthma. The aim of this study was to e...

Descripción completa

Detalles Bibliográficos
Autores principales: Puggioni, Francesca, Brussino, Luisa, Canonica, Giorgio Walter, Blasi, Francesco, Paggiaro, Pierluigi, Caminati, Marco, Latorre, Manuela, Heffler, Enrico, Senna, Gianenrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667506/
https://www.ncbi.nlm.nih.gov/pubmed/33204116
http://dx.doi.org/10.2147/JAA.S274245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667506/
https://www.ncbi.nlm.nih.gov/pubmed/33204116
http://dx.doi.org/10.2147/JAA.S274245

Ejemplares similares